US20090317341A1 - Compositions for Lightening Skin Color - Google Patents
Compositions for Lightening Skin Color Download PDFInfo
- Publication number
- US20090317341A1 US20090317341A1 US12/141,561 US14156108A US2009317341A1 US 20090317341 A1 US20090317341 A1 US 20090317341A1 US 14156108 A US14156108 A US 14156108A US 2009317341 A1 US2009317341 A1 US 2009317341A1
- Authority
- US
- United States
- Prior art keywords
- acid
- cosmetic composition
- heterosubstituted
- integer
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Abstract
Skin lightening additives and skin lightening compositions having at least one of a heterosubstituted, saturated or unsaturated aliphatic acid are described. The compositions are suitable for topical application and may comprise 12-hydroxystearic acid, ricinoleic acid or both.
Description
- The present invention is directed to a skin lightening additive as well as compositions comprising the same. More particularly, the present invention is directed to a cosmetic composition comprising a skin lightening additive whereby the skin lightening additive comprises a heterosubstituted, saturated or unsaturated aliphatic acid, or a mixture thereof. The skin lightening additive, when used, results in a cosmetic composition that can provide moisturizing benefits. Moreover, it has been unexpectedly discovered that such aliphatic acids have skin lightening benefits when topically applied.
- Many consumers are concerned with the characteristics of their skin. For example, consumers are concerned with the degree of pigmentation of their skin, freckles and/or age spots. Other consumers wish to reduce skin darkening caused by exposure to sunlight. To meet the needs of consumers, many attempts have been made to develop products that improve skin characteristics. The products developed thus far, however, often tend to have low efficacy, undesirable side effects or both. Furthermore, such products can be expensive and are often not an alternative for lower income consumers.
- There is an increasing interest to develop a cosmetic composition that comprises new skin lightening additives. This invention, therefore, is directed to cosmetic compositions that comprise new skin lightening additives. The cosmetic compositions of the present invention preferably comprise, as a lightening additive, compounds like 12-hydroxystearic acid, ricinoleic acid or both. The cosmetic compositions of this invention result in a decrease in melanin content which is at least about 8% lower (preferably, at least about 11% lower) when comparing MelanoDerm™ cultures treated with the same to MelanoDerm cultures that have not been subjected to a composition with the newly discovered skin lightening additives of this invention.
- Efforts have been disclosed for making skin care cosmetic compositions. In U.S. Pat. No. 6,875,425, skin lightening agents with 4-substituted resorcinol derivative compounds are described.
- Other efforts have been disclosed for making skin treatment compositions. In U.S. Pat. Nos. 7,250,158 and 7,247,294, methods for treating with skin lightening agents are described.
- Still other efforts have been disclosed for treating skin. In U.S. Pat. No. 5,998,423, compositions with polycyclic nitrogen heterocycles are described.
- None of the additional information above describes skin lightening compositions that comprise, as a lightening additive, a heterosubstituted, saturated or unsaturated aliphatic acid, or mixture thereof.
- In a first aspect, the present invention is directed to a skin lightening additive, the skin lightening additive comprising a heterosubstituted, saturated or unsaturated aliphatic acid, or both.
- In a second aspect, the present invention is directed to a cosmetic composition for skin lightening, the cosmetic composition comprising a skin lightening agent comprising the skin lightening additive of the first aspect of this invention.
- In a third aspect, the present invention is directed to a method for lightening skin with the cosmetic composition of the second aspect of this invention.
- All other aspects of the present invention will more readily become apparent upon considering the detailed description and examples which follow.
- As used herein, a decrease in melanin content means a melanin content decrease when comparing two (2), three week old MatTek MelanoDerm cultures that have not been treated with a composition comprising the skin lightening additive of this invention to two (2), three week old MatTek MelanoDerm cultures that have been treated with a composition comprising the skin lightening additive of this invention wherein treated means:
-
- (a) placing the MelanoDerm culture within a six (6) well tissue culture dish and set about 0.3 cm off of the tissue culture dish;
- (b) subjecting the MelanoDerm culture to 0.1 and 5 micromolar compositions having the skin lightening additive of this invention, the composition being one prepared from a 10 millimolar solution of skin lightening additive and carrier (e.g., dimethyl sulfoxide) having been diluted with Dulbecco's Modified Eagle Media; and
- (c) comparing the treated and untreated cultures by obtaining average melanin content (expressed in micrograms) by extracting melanin from MelanoDerm and obtaining absorbance readings at 490 nm (OD490) using a commercially available spectrophotometer like a Hach Spectrophotometer.
- Cosmetic composition, as used herein, is meant to include a composition for topical application to skin of mammals, especially humans. Such a composition may be generally classified as leave-on or rinse off, and is meant to include conditioners or tonics, lipsticks, color cosmetics, and general topical compositions that in some fashion and at the very least, reduce the effect of melanin on keratinocytes. Lightening and whitening as used herein are meant to mean the same and they include the lightening of skin directly as well as the lightening of spots on the skin, like age spots and freckles. Dulbecco's Modified Eagle Media means the nutrient solution sold by MatTek Corporation and treated and used according to instructions supplied with the product commercially identified as MEL3001OBBLLMM. Skin lightening additive means a component suitable to result in physical, but especially biological whitening (i.e., a reduction in melanin production) whereby the skin lightening additive can comprise, consist essentially of or consist of the skin lightening additive. MelanoDerm means the product having normal, human-derived epidermal keratinocytes and melanocytes which have been cultured to form a multilayered, highly differentiated model of the human epidermis, all of which is made commercially available by MatTek Corporation. Unsaturated, as used herein, means having at least one bond that is not sp3 hybridized. Comprising, as used herein, is meant to include consisting essentially of and consisting of.
- The cosmetic composition of the present invention can be in the form of a liquid, lotion, cream, serum, gel, soap bar or toner, or applied via a face mask or patch. The composition of this invention is one that at the very least, lightens skin when skin is meant to include skin on the face, neck, chest, back, arms, hands, legs and scalp. All ranges identified herein are meant to implicitly include all ranges subsumed therein, if, for example, reference to the same is not explicitly made.
- The only limitation with respect to the skin lightening additive that may be used in this invention is that the same may be used in a topical composition suitable for use on humans. The preferred additive is a heterosubstituted, saturated or unsaturated aliphatic acid or a mixture thereof.
- In a most preferred embodiment, the skin lightening additive employed in the present invention comprises a compound having the formulae:
- or a mixture thereof,
wherein each R is independently hydrogen, hydroxyl, C1-6 alkoxy, C1-6 alkyl, arylalkyl or an amine, with the proviso that at least one R group comprises a heteroatom; each R1 is independently hydrogen, C1-6 alkoxy, C1-6 alkyl, arylalkyl or an amine; n is an integer from about 7 to about 19; and s and e are each independently an integer from about 0 to about 8, where s+e≧6 ; q is an integer from about 6 to about 11; each r is independently an integer from 0 to 1, with the proviso that each r is not 1 when x is 1; x is an integer from 0 to 1 with the proviso that x is 0 when at least one r is 1; and each t is independently an integer from 1 to 7. - The preferred compounds suitable for use in this invention (either alone or in a mixture) are aleuritic acid; phloionolic acid; 9,10,13-trihydroxy-11-octadecenoic acid; 9,13-dihydroxy-12-ethoxy-10-octadecenoic acid; 9-hydroxy-10,12-octadecadienoic acid; 4,14-dihydroxy-octadecanoic acid; 12-hydroxystearic acid(12-hydroxyoctadecanoic acid); lesquerolic acid; ricinelaidic acid; ambrettolic acid, and rincinoleic acid (12-hydroxy-9-cis-octadecanoic acid) as represented by either formula I or II. Other preferred compounds suitable for use in this invention include beta-dimorphecolic acid; densipolic acid; 8-methoxy-13-hydroxy-9,11-octadecadienoic acid; 7-oxo-octadecanoic acid; 9-oxo-octadecanoic acid; 12-oxo-octadecanoic acid and 10-oxo-14-methyl-pentadecanoic acid as represented by formula III. Furthermore it is within the scope of the present invention to include any derivative (like an ester derivative) and/or salt of the acid represented by formulae I-III, and especially, Mg, Na and/or Ca salts thereof. Such compounds are commercially available from suppliers like Vertellus Specialties, Inc., Welch, Home & Clark Co., Inc., as well as Croda Chemicals.
- The cosmetic compositions of the present invention typically comprise from about 0.001 to about 15% by weight, and preferably, from about 0.1 to about 12%, and most preferably, from about 1 to about 10% by weight skin lightening additive, based on total weight of the cosmetic composition and including all ranges subsumed therein.
- While it is within the scope of this invention for the skin lightening additive to consist essentially of and to consist of heterosubstituted, saturated or unsaturated aliphatic acid or a mixture thereof, in an often desired embodiment, the skin lightening additive of this invention comprises from about 0.2 to about 95%, and preferably, from about 10 to about 85%, and most preferably, from about 30 to about 65% by weight heterosubstituted saturated or unsaturated aliphatic acid, or a mixture thereof, based on total weight of skin lightening additive and including all ranges subsumed therein.
- In yet another desired embodiment, the cosmetic composition of this invention comprises from about 2 to about 9%, and preferably, from about 3 to 8%, and most preferably, from about 3 to about 6% by weight heterosubstituted, saturated or unsaturated aliphatic acid, or a mixture thereof, based on total weight of the cosmetic composition and including all ranges subsumed therein.
- When used in combination, the weight ratio of heterosubstituted, saturated or unsaturated aliphatic acid to heterosubstituted, saturated aliphatic acid is from about 5:95 to about 95:5, and preferably, from about 20:80 to about 80:20, and most preferably, from about 40:60 to about 60:40, including all ratios subsumed therein.
- It should be known that commercially acceptable and conventional vehicles may be used, acting as diluents, dispersants and/or carriers for the skin lightening agents and additives described herein and for any other optional but often preferred additives. Therefore, the cosmetically acceptable vehicle suitable for use in this invention may be aqueous-based, anhydrous or an emulsion whereby a water-in-oil or oil-in-water emulsion is generally preferred. If the use of water is desired, water typically makes up the balance of the cosmetic composition, and preferably, makes up from about 5 to about 99%, and most preferably, from about 40 to about 80% by weight of the cosmetic composition, including all ranges subsumed therein.
- In addition to water, organic solvents may be optionally included to act as carriers or to assist carriers within the compositions of the present invention. Illustrative and non-limiting examples of the types of organic solvents suitable for use in the present invention include alkanols like ethyl and isopropyl alcohol, mixtures thereof or the like.
- Other optional additives suitable for use include ester oils like isopropyl myristate, cetyl myristate, 2-octyldodecyl myristate, avocado oil, almond oil, olive oil, neopentylglycol dicaprate, mixtures thereof or the like. Typically, such ester oils assist in emulsifying the cosmetic composition of this invention, and an effective amount is often used to yield a stable, and most preferably, water-in-oil emulsion.
- Emollients may also be used, if desired, as carriers within the cosmetic composition of the present invention. Alcohols like 1-hexadecanol (i.e., cetyl alcohol) and phenoxyethanol are often desired as are the emollients generally classified as silicone oils and synthetic esters. Silicone oils suitable for use include cyclic or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms. Nonvolatile silicone oils useful as an emollient material in the inventive cosmetic composition described herein include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially non-volatile polyalkyl siloxanes useful herein include, for example, polydimethylsiloxanes.
- The ester emollients that may optionally be used are:
-
- (1) Alkenyl or alkyl esters of fatty acids having 10 to 20 carbon atoms.
- Examples thereof include isoarachidyl neopentanoate, isononyl isonanonoate, oleyl myristate, oleyl stearate, and oleyl oleate.
-
- (2) Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.
- (3) Polyhydric alcohol esters. Ethylene glycol mono and di-fatty acid esters, diethylene glycol mono-and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl mono-stearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters.
- (4) Wax esters such as beeswax, spermaceti, stearyl stearate and arachidyl behenate.
- (5) Sterols esters, of which cholesterol fatty acid esters are examples.
- Emollients when used, typically make up from about 0.1 to about 50% by weight of the cosmetic composition, including all ranges subsumed therein.
- Fatty acids having from 10 to 30 carbon atoms may also be included as cosmetically acceptable carriers within the composition of the present invention. Illustrative examples of such fatty acids include pelargonic, lauric, myristic, palmitic, stearic, isostearic, oleic, linoleic, arachidic, behenic or erucic acid, and mixtures thereof. Compounds that are believed to enhance skin penetration, like dimethyl sulfoxide, may also be used as an optional carrier.
- Humectants of the polyhydric alcohol type may also be employed in the cosmetic compositions of this invention. The humectant often aids in increasing the effectiveness of the emollient, reduces scaling, stimulates removal of built-up scale and improves skin feel. Typical polyhydric alcohols include glycerol, polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. For best results the humectant is preferably propylene glycol or sodium hyaluronate. The amount of humectant may range anywhere from 0.2 to 25%, and preferably, from about 0.5 to about 15% by weight of the cosmetic composition, based on total weight of the cosmetic composition and including all ranges subsumed therein.
- Thickeners may also be utilized as part of the cosmetically acceptable carrier in the cosmetic compositions of the present invention. Typical thickeners include cross-linked acrylates (e.g. Carbopol 982), hydrophobically-modified acrylates (e.g. Carbopol 1382), cellulosic derivatives and natural gums. Among useful cellulosic derivatives are sodium carboxymethylcellulose, hydroxypropyl methylcellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, ethyl cellulose and hydroxymethyl cellulose. Natural gums suitable for the present invention include guar, xanthan, sclerotium, carrageenan, pectin and combinations of these gums. Amounts of the thickener may range from 0.0 to 5%, usually from 0.001 to 1%, optimally from 0.01 to 0.5% by weight.
- Collectively, the water, solvents, silicones, esters, fatty acids, humectants and/or thickeners will constitute the cosmetically acceptable carrier in amounts from 1 to 99.9%, preferably from 80 to 99% by weight.
- Surfactants may also be present in cosmetic compositions of the present invention. Total concentration of the surfactant will range from about 0 to about 40%, and preferably, from about 0 to about 20%, optimally from about 0 to about 5% by weight of the composition. The surfactant may be selected from the group consisting of anionic, nonionic, cationic and amphoteric actives. Particularly preferred nonionic surfactants are those with a C10-C20 fatty alcohol or acid hydrophobe condensed with from 2 to 100 moles of ethylene oxide or propylene oxide per mole of hydrophobe; C2-C10 alkyl phenols condensed with from 2 to 20 moles of alkylene oxide; mono- and di- fatty acid esters of ethylene glycol; fatty acid monoglyceride; sorbitan, mono- and di- C8-C20 fatty acids; block copolymers (ethylene oxide/propylene oxide); and polyoxyethylene sorbitan as well as combinations thereof. Alkyl polyglycosides and saccharide fatty amides (e.g. methyl gluconamides) are also suitable nonionic surfactants.
- Preferred anionic surfactants include soap, alkyl ether sulfate and sulfonates, alkyl sulfates and sulfonates, alkylbenzene sulfonates, alkyl and dialkyl sulfosuccinates, C8-C20 acyl isothionates, acyl glutamates, C8-C20 alkyl ether phosphates and combinations thereof.
- Perfumes may be used in the cosmetic composition of this invention. Illustrative non-limiting examples of the types of perfumes that may be used include those comprising terpenes and terpene derivatives like those described in Bauer, K., et al., Common Fragrance and Flavor Materials, VCH Publishers (1990).
- Illustrative yet non-limiting examples of the types of fragrances that may be used in this invention include myrcene, dihydromyrenol, citral, tagetone, cis-geranic acid, citronellic acid, or cis-geranic acid nitrile, mixtures thereof or the like.
- Preferably, the amount of fragrance employed in the cosmetic composition of this invention is in the range from about 0.0% to about 10%, more preferably, about 0.00001% to about 5 wt %, most preferably, about 0.0001% to about 2%.
- Various types of optional additional active ingredients may be used in the cosmetic compositions of the present invention. Actives are defined as skin benefit agents other than emollients and other than ingredients that merely improve the physical characteristics of the composition. Although not limited to this category, general examples include talcs and silicas, as well as alpha-hydroxy acids, beta-hydroxy acids, peroxides, zinc salts, and sunscreens.
- Beta-hydroxy acids include salicylic acid, for example. Zinc pyrithione is an example of the zinc salts useful in the cosmetic composition of the present invention.
- Sunscreens include those materials commonly employed to block ultraviolet light. Illustrative compounds are the derivatives of PABA, cinnamate and salicylate. For example, avobenzophenone (Parsol 1789®) octyl methoxycinnamate and 2-hydroxy-4-methoxyl benzophenone (also known as oxybenzone) can be used. Octyl methoxycinnamate and 2-hydroxy-4-methoxy benzophenone are commercially available under the trademarks, Parsol MCX and Benzophenone-e, respectively. The exact amount of sunscreen employed in the compositions can vary depending upon the degree of protection desired from the sun's UV radiation. Additives that reflect or scatter the suns rays may also be employed. These additives include oxides like zinc oxide and titanium dioxide.
- Many cosmetic compositions, especially those containing water, should be protected against the growth of potentially harmful microorganisms. Anti-microbial compounds, such as triclosan, and preservatives are, therefore, typically necessary. Suitable preservatives include alkyl esters of p-hydroxybenzoic acid, hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds. Particularly preferred preservatives of this invention are methyl paraben, propyl paraben, phenoxyethanol and benzyl alcohol. Preservatives will usually be employed in amounts ranging from about 0.1% to 2% by weight of the composition.
- Still other optional ingredients that may be used with the cosmetic composition of this invention include dioic acids (e.g., malonic acid, sebacic acid), antioxidants like vitamin E, vitamins, like niacinamide and vitamin C and its derivatives, recorcinols and its derivatives (including those esterified with, for example, ferulic acid, vanillic acid or the like) and retinoids, including retinoic acid, retinal, retinol and retinyl esters, conjugated linoleic acid, petroselinic acid and mixtures thereof, as well as any other conventional ingredients well known for wrinkle-reducing, skin whitening, anti-acne effects and reducing the impact of sebum.
- The cosmetic compositions of the present invention are intended for use primarily as a product for topical application to human skin, especially and at least as a product for lightening the skin. Thus, the inventor has discovered that the described aliphatic acids have excellent skin lightening capabilities whereby the same may be employed as skin lightening additives in topical cosmetic compositions that are applied topically to areas of the skin where lightening or whitening is desired. Other benefits may include skin moisturizing, decreasing the effect of sebum on the skin and skin wrinkle reducing. Often, the cosmetic composition of the present invention has a melting point from about 30° C. to about 45° C., including all ranges subsumed therein. In an especially preferred embodiment, the cosmetic composition of the present invention has a pH from about 4.5 to about 7.5, including all ranges subsumed therein.
- When making the cosmetic composition of the present invention, the desired ingredients are mixed in no particular order and usually at temperatures from about 70 to about 80° C. and under atmospheric pressure.
- The packaging for the composition of this invention can be a patch, bottle, tube, roll-ball applicator, propellant driven aerosol device, squeeze container or lidded jar.
- The examples which follow are provided to illustrate and facilitate an understanding of the invention. The examples are not intended to limit the scope of the claims.
- Commercially available human skin equivalents (MelanoDerm™ from MatTek) were obtained for testing the impact of heterosubstituted, saturated or unsaturated aliphatic acid on melanogenesis. Solutions having a final concentration of 0.1 to 5 micromolar were prepared from a 10 millimolar dimethyl sulfoxide stock solution and dosed ten (10) times in a three (3) week period into the media of the MelanoDerm cultures. The media consisted of commercially available basal Dulbecco's Modified Eagles media, prepared and treated in the manner set forth in the manufacturer's instructions. For long term maintenance of the MelanoDerms, the basal media was supplemented with bFGF and alpha MSH to stimulate melanocyte growth and melanogenesis. Each treatment condition was done in duplicate and three (3) sets were made for each treatment, as well as for a control (culture not treated with the aliphatic acid). The cultures were maintained at a temperature of about 37° C. and incubated in a humidified, 5% CO2 incubator during the dosing period, but removed while being dosed.
- After a three (3) week period, the MelanoDerm cultures were removed and solubilized in a centrifuge tube containing 250 microliters of Solvable reagent (GNE9100, Packard) for sixteen (16) hours (overnight) in a 60° C. oven. Following solubilization, the centrifuge tube containing the sample was spun at 12,000 g for five (5) minutes. Two hundred (200) microliters of supernatant were removed and placed in a ninety-six (96) well plate. A spectrophotometer was used to measure the absorbance of the supernatant at 490 nm. A standard curve using synthetic melanin was set up in parallel to allow quantitation of melanin, in micrograms, of the samples. The results are provided below:
-
TABLES Active Average MC ΔMC MC* Value Range Control 76.0-78.4 77.2 — Aliphatic acidi 67.9-69.2 68.6 8.6 MC Value Range Control 76.0-78.4 77.2 — Aliphatic acidii 69.9-67.6 68.8 8.4 i= ricinoleic acid (0.1 uM) ii= 12-hydroxystearic acid (5 uM) *MC = melanin content - The results, as they relate to MelanoDerm cultures, show that cosmetic compositions with the aliphatic acids of this invention unexpectedly result in skin lightening.
Claims (19)
1. A skin lightening additive comprising a heterosubstituted, saturated or unsaturated aliphatic acid, or a mixture thereof.
2. The skin lightening additive according to claim 1 wherein aliphatic acid is
or a mixture thereof
wherein each R is independently hydrogen, hydroxyl, C1-6 alkoxy, C1-6 alkyl, arylalkyl or an amine, with the proviso that at least one R group comprises a heteroatom; each R1 is independently hydrogen, C1-6 alkoxy, C1-6 alkyl, arylalkyl or an amine; n is an integer from about 7 to about 19; and s and e are each independently an integer from about 0 to about 8, where s+e≧6; q is an integer from about 6 to about 11; each r is independently an integer from 0 to 1, with the proviso that each r is not 1 when x is 1; x is an integer from 0 to 1 with the proviso that x is 0 when at least one r is 1; and each t is independently an integer from 1 to 7.
3. The skin lightening additive according to claim 1 wherein the heterosubstituted, saturated aliphatic acid is at least one of aleuritic acid; phloionolic acid, 9,10,13-trihydroxy-11-octadecenoic acid; 9,13-dihydroxy-12-ethoxy-10-octadecenoic acid; 9-hydroxy-10,12-octadecadienoic acid; 4,14-dihydroxy-octadecanoic acid; 12-hydroxystearic acid or a mixture thereof and the heterosubstituted, unsaturated aliphatic acid is at least one of lesquerolic acid; ricinelaidic acid; ambrettolic acid; ricinoleic acid; beta-dimorphecolic acid; densipolic acid; 8-methoxy-13-hydroxy-9,11-octadecadienoic acid; 7-oxo-octadecanoic acid; 9-oxo-octadecanoic acid; 12-oxo-octadecanoic acid; 10-oxo-14-methyl-pentadecanoic acid or a mixture thereof.
4. The skin lightening additive according to claim 1 wherein the skin lightening additive comprises the heterosubstituted, saturated aliphatic acid and heterosubstituted, unsaturated aliphatic acid at a weight ratio from about 10:90 to about 90:10.
5. The skin lightening additive according to claim 1 wherein the skin lightening additive consists essentially of heterosubstituted, saturated aliphatic acid, heterosubstituted, unsaturated aliphatic acid, or both.
6. A cosmetic composition comprising
a. a skin lightening additive comprising a heterosubstituted, saturated or unsaturated aliphatic acid, or a mixture thereof; and
b. a cosmetic carrier.
7. The cosmetic composition according to claim 6 wherein aliphatic acid is represented as formula I, formula II and/or formula III
or a mixture thereof
wherein each R is independently hydrogen, hydroxyl, C1-6 alkoxy, C1-6 alkyl, arylalkyl or an amine, with the proviso that at least one R group comprises a heteroatom; each R1 is independently hydrogen, C1-6 alkoxy, C1-6 alkyl, arylalkyl or an amine; n is an integer from about 7 to about 19; and s and e are each independently an integer from about 0 to about 8, where s+e≧6; q is an integer from about 6 to about 11; each r is independently an integer from 0 to 1, with the proviso that each r is not 1 when x is 1; x is an integer from 0 to 1 with the proviso that x is 0 when at least one r is 1; and each t is independently an integer from 1 to 7.
8. The cosmetic composition according to claim 7 wherein the heterosubstituted, saturated aliphatic acid is at least one of aleuritic acid; phloionolic acid; 9,10,13-trihydroxy-11-octadecenoic acid; 9,13-dihydroxy-12-ethoxy-10-octadecenoic acid; 9-hydroxy-10,12-octadecadienoic acid; 4,14-dihydroxy-octadecanoic acid; 12-hydroxystearic acid or a mixture thereof and the heterosubstituted, unsaturated aliphatic acid is at least one of lesquerolic acid; ricinelaidic acid, ambrettolic acid; ricinoleic acid; beta-dimorphecolic acid; densipolic acid; 8-methoxy-13-hydroxy-9,11-octadecadienoic acid; 7-oxo-octadecanoic acid; 9-oxo-octadecanoic acid; 12-oxo-octadecanoic acid; 10-oxo-14-methyl-pentadecanoic acid or a mixture thereof.
9. The cosmetic composition according to claim 6 wherein the skin lightening additive comprises the heterosubstituted, saturated aliphatic acid and heterosubstituted, unsaturated aliphatic acid at a weight ratio from about 90:10 to about 10:90.
10. The cosmetic composition according to claim 6 wherein the skin lightening additive consists essentially of heterosubstituted, saturated aliphatic acid, heterosubstituted, unsaturated aliphatic acid, or a mixture thereof.
11. The cosmetic composition according to claim 6 wherein the cosmetic composition further comprises an alpha-hydroxy, beta-hydroxy acid, sunscreen or a mixture thereof.
12. The cosmetic composition according to claim 6 wherein the cosmetic composition further comprises a vitamin.
13. The cosmetic composition according to claim 12 wherein the vitamin is niacinamide.
14. The cosmetic composition according to claim 7 wherein the cosmetic composition further comprises niacinamide.
15. The cosmetic composition according to claim 6 wherein the composition further comprises conjugated linoleic acid, petroselinic acid or both.
16. The cosmetic composition according to claim 6 wherein the composition further comprises antioxidant.
17. The cosmetic composition according to claim 7 whereby a salt or derivative of the aliphatic acid represented by formula I, II and/or III is used.
18. A method for lightening skin color comprising the steps of:
a. contacting skin with the composition of claim 6 ; and
b. suppressing melanin production.
19. The method for lightening skin color according to claim 17 wherein the skin composition further comprise niacinamide, conjugated linoleic acid, petroselinic acid, sunscreen, alpha-hydroxy acid, beta-hydroxy acid or a mixture thereof.
Priority Applications (31)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/141,561 US20090317341A1 (en) | 2008-06-18 | 2008-06-18 | Compositions for Lightening Skin Color |
JP2011513979A JP5620908B2 (en) | 2008-06-18 | 2009-06-04 | Composition for whitening skin color |
KR1020167010797A KR101788998B1 (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
MX2010014098A MX2010014098A (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color. |
CN201711095416.6A CN108158836A (en) | 2008-06-18 | 2009-06-04 | For the method for blast skin |
EP14163576.3A EP2752184B1 (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
AU2009259483A AU2009259483B2 (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
EA201300756A EA026945B1 (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
KR1020107028407A KR101617478B1 (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
EP16177361.9A EP3103434B1 (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
EA201170042A EA018806B1 (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
CN200980122854.4A CN102065829B (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
ES14163576.3T ES2611791T3 (en) | 2008-06-18 | 2009-06-04 | Compositions to lighten skin color |
CA2728978A CA2728978C (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
BRPI0914843-4A BRPI0914843B1 (en) | 2008-06-18 | 2009-06-04 | COSMETIC COMPOSITION AND METHOD FOR LIGHTENING SKIN COLOR |
EP09765749.8A EP2285342B9 (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
PL09765749T PL2285342T3 (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
CN201410170094.7A CN103976889B (en) | 2008-06-18 | 2009-06-04 | Method for blast skin |
PL14163576T PL2752184T3 (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
ES09765749.8T ES2511916T3 (en) | 2008-06-18 | 2009-06-04 | Skin color lightening compositions |
PCT/EP2009/056886 WO2009153169A1 (en) | 2008-06-18 | 2009-06-04 | Compositions for lightening skin color |
SA109300373A SA109300373B1 (en) | 2008-06-18 | 2009-06-10 | Compositions for Lightening Skin Color |
TW098119831A TWI442943B (en) | 2008-06-18 | 2009-06-12 | Compositions for lightening skin color |
ARP090102190A AR072165A1 (en) | 2008-06-18 | 2009-06-17 | COMPOSITIONS TO CLEAR UP THE COLOR OF THE SKIN. SKIN CLEARING ADDITIVE. METHOD. |
US12/908,248 US9227090B2 (en) | 2008-06-18 | 2010-10-20 | Method for lightening skin |
ZA2010/08792A ZA201008792B (en) | 2008-06-18 | 2010-12-07 | Compositions for lightening skin color |
CL2010001461A CL2010001461A1 (en) | 2008-06-18 | 2010-12-17 | Cosmetic composition comprising a skin lightening additive that is 12-hydroxystearic acid and / or a salt, a cosmetic carrier and niacinamide; and a method to clarify skin color. |
HK11108430.8A HK1153954A1 (en) | 2008-06-18 | 2011-08-11 | Compositions for lightening skin color |
HK15101435.4A HK1200737A1 (en) | 2008-06-18 | 2015-02-10 | A method for lightening skin |
US14/948,461 US20160074295A1 (en) | 2008-06-18 | 2015-11-23 | Method for lightening skin with ricinoleic acid |
US16/380,657 US20190336424A1 (en) | 2008-06-18 | 2019-04-10 | Method for lightening skin with ricinoleic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/141,561 US20090317341A1 (en) | 2008-06-18 | 2008-06-18 | Compositions for Lightening Skin Color |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/908,248 Continuation US9227090B2 (en) | 2008-06-18 | 2010-10-20 | Method for lightening skin |
US12/908,248 Division US9227090B2 (en) | 2008-06-18 | 2010-10-20 | Method for lightening skin |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090317341A1 true US20090317341A1 (en) | 2009-12-24 |
Family
ID=41120037
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/141,561 Abandoned US20090317341A1 (en) | 2008-06-18 | 2008-06-18 | Compositions for Lightening Skin Color |
US12/908,248 Active US9227090B2 (en) | 2008-06-18 | 2010-10-20 | Method for lightening skin |
US14/948,461 Abandoned US20160074295A1 (en) | 2008-06-18 | 2015-11-23 | Method for lightening skin with ricinoleic acid |
US16/380,657 Abandoned US20190336424A1 (en) | 2008-06-18 | 2019-04-10 | Method for lightening skin with ricinoleic acid |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/908,248 Active US9227090B2 (en) | 2008-06-18 | 2010-10-20 | Method for lightening skin |
US14/948,461 Abandoned US20160074295A1 (en) | 2008-06-18 | 2015-11-23 | Method for lightening skin with ricinoleic acid |
US16/380,657 Abandoned US20190336424A1 (en) | 2008-06-18 | 2019-04-10 | Method for lightening skin with ricinoleic acid |
Country Status (19)
Country | Link |
---|---|
US (4) | US20090317341A1 (en) |
EP (3) | EP3103434B1 (en) |
JP (1) | JP5620908B2 (en) |
KR (2) | KR101788998B1 (en) |
CN (3) | CN108158836A (en) |
AR (1) | AR072165A1 (en) |
AU (1) | AU2009259483B2 (en) |
BR (1) | BRPI0914843B1 (en) |
CA (1) | CA2728978C (en) |
CL (1) | CL2010001461A1 (en) |
EA (2) | EA018806B1 (en) |
ES (2) | ES2611791T3 (en) |
HK (2) | HK1153954A1 (en) |
MX (1) | MX2010014098A (en) |
PL (2) | PL2752184T3 (en) |
SA (1) | SA109300373B1 (en) |
TW (1) | TWI442943B (en) |
WO (1) | WO2009153169A1 (en) |
ZA (1) | ZA201008792B (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012062554A2 (en) | 2010-11-11 | 2012-05-18 | Unilever Plc | Leave-on non-solid skin conditioning compositions containing 12-[(12-hydroxyoctadecanoyl)oxy] octadecanoic acid |
WO2012061991A1 (en) | 2010-11-11 | 2012-05-18 | Unilever Plc | Leave-on nonsolid skin conditioning compositions containing 12-hydroxystearic acid |
WO2012080272A2 (en) | 2010-12-15 | 2012-06-21 | Unilever Plc | Leave-on non-solid skin conditioning compositions containing 12-hydroxystearic acid and ethoxylated hydrogenated castor oil |
WO2012110276A1 (en) | 2011-02-17 | 2012-08-23 | Unilever Plc | Leave -on non- solid skin conditioning composition which has a continuous phase and contains 12 - hydroxystearic acid |
WO2013068345A2 (en) | 2011-11-11 | 2013-05-16 | Unilever Plc | Organogel structured with 12-hsa and a selected copolymer |
WO2014095257A1 (en) * | 2012-12-20 | 2014-06-26 | Unilever N.V. | Eutectic mixtures in personal care compositions |
US9539190B2 (en) | 2010-05-07 | 2017-01-10 | Conopco, Inc. | Skin conditioning compositions containing 12-hydroxystearic acid |
US9597271B2 (en) | 2013-10-24 | 2017-03-21 | The Procter & Gamble Company | Cosmetic compositions and methods |
US9956257B2 (en) | 2005-10-27 | 2018-05-01 | KGK Science, Inc. | Canola extracts containing high levels of phenolic acids |
US10172772B2 (en) * | 2013-01-31 | 2019-01-08 | KGK Science, Inc. | Methods of skin whitening by use of canola extracts |
US10660836B2 (en) | 2015-12-22 | 2020-05-26 | Conopco, Inc. | Hydroxy functionalized solvent based skin benefit composition |
US20220202670A1 (en) * | 2020-12-30 | 2022-06-30 | Galaxy Surfactants Ltd. | Personal and home care compositions comprising fatty acids from tung seed oil as antimicrobial preservative |
CN116056684A (en) * | 2020-07-30 | 2023-05-02 | 联合利华知识产权控股有限公司 | Personal care compositions comprising atractylenolide-I or a source of atractylenolide-I |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090317341A1 (en) * | 2008-06-18 | 2009-12-24 | Conopco, Inc., D/B/A Unilever | Compositions for Lightening Skin Color |
DE102010056550A1 (en) | 2010-12-30 | 2012-07-05 | Evonik Goldschmidt Gmbh | Use of 13-hydroxy-9,11-octadecadienoic acid for tanning human skin |
EP2604248B1 (en) | 2011-12-13 | 2017-10-25 | Unilever PLC | Oil-in-water cosmetic composition |
EP3334403B1 (en) | 2015-08-10 | 2021-03-31 | Mary Kay, Inc. | Topical compositions |
JP6880011B2 (en) * | 2015-10-05 | 2021-06-02 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Skin whitening composition |
CN109069384B (en) * | 2016-04-13 | 2022-10-18 | 帝斯曼知识产权资产管理有限公司 | 10-hydroxystearic acid composition |
BR112018077141B1 (en) * | 2016-07-27 | 2022-02-01 | Unilever Ip Holdings B.V. | Personal care composition and uses of a skin care composition |
WO2018113637A1 (en) * | 2016-12-21 | 2018-06-28 | Unilever Plc | Personal care compositions with glutathione precursor comprising nicotinamide and amino acids |
CN110325168B (en) | 2016-12-21 | 2022-10-21 | 联合利华知识产权控股有限公司 | Personal care compositions containing cystine |
CA3046721A1 (en) | 2016-12-21 | 2018-06-28 | Unilever Plc | Personal care compositions comprising poorly soluble compounds |
CN110121329B (en) * | 2016-12-21 | 2022-04-12 | 联合利华知识产权控股有限公司 | Topical skin lightening additives and compositions with amino acids and PPAR-activated fatty acids |
JP2020502087A (en) * | 2016-12-21 | 2020-01-23 | ユニリーバー・ナームローゼ・ベンノートシヤープ | External skin lightening additive and composition containing amino acid and nicotinamide compound |
US11260005B2 (en) | 2016-12-21 | 2022-03-01 | Conopco, Inc. | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
WO2019183494A1 (en) | 2018-03-23 | 2019-09-26 | Mary Kay Inc. | Topical compositions and methods |
CN111110607B (en) * | 2020-02-26 | 2020-12-15 | 李应坤 | Mild moisturizing type foam facial cleanser and preparation method thereof |
WO2022226209A1 (en) * | 2021-04-22 | 2022-10-27 | Glo Pharma, Inc. | Skin peel compositions |
WO2023061962A1 (en) | 2021-10-13 | 2023-04-20 | Unilever Ip Holdings B.V. | A personal care composition comprising vitamin k2 and hydroxystearic acid |
WO2023151986A1 (en) | 2022-02-09 | 2023-08-17 | Unilever Ip Holdings B.V. | A skin brightening composition |
Citations (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4096240A (en) * | 1975-04-10 | 1978-06-20 | Lever Brothers Company | Skin lightening composition and method |
JPH05201847A (en) * | 1992-01-28 | 1993-08-10 | Sunstar Inc | Skin-beautifying cosmetic |
US5262153A (en) * | 1989-09-20 | 1993-11-16 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkujo | Skin-whitening agent |
US5399785A (en) * | 1992-08-05 | 1995-03-21 | Nippon Paint Co., Ltd. | Tyrosinase activity inhibitor |
US5429816A (en) * | 1992-05-12 | 1995-07-04 | Procter & Gamble | Antiperspirant gel stick compositions |
US5516511A (en) * | 1994-05-06 | 1996-05-14 | The Procter & Gamble Company | Antiperspirant gel compositions comprising chelators |
US5591424A (en) * | 1993-06-30 | 1997-01-07 | The Procter & Gamble Company | Antiperspirant gel stick compositions |
US5744130A (en) * | 1996-12-20 | 1998-04-28 | The Procter & Gamble Company | Antiperspirant gel-solid stick compositions substantially free of select polar solvents |
US5776494A (en) * | 1996-12-20 | 1998-07-07 | The Procter & Gamble Company | Pharmaceuticals compositions containing gellants in the form of alkyl amides of di-and tri-carboxylic acids |
US5863546A (en) * | 1997-03-02 | 1999-01-26 | Swinehart; James M | Cosmetic composition |
US5965113A (en) * | 1997-06-23 | 1999-10-12 | Procter & Gamble Company | Low residue antiperspirant gel-solid stick compositions containing volatile nonpolar hydrocarbon solvents |
US5968489A (en) * | 1998-05-01 | 1999-10-19 | The Procter & Gamble Company | Antiperspirant composition containing 1,2-hexanediol |
US5998423A (en) * | 1996-10-08 | 1999-12-07 | Therasys, Inc. | Methods for modulating melanin production |
US6033651A (en) * | 1998-06-10 | 2000-03-07 | Revlon Consumer Products Corporation | Gel cosmetic compositions |
US6090369A (en) * | 1997-06-04 | 2000-07-18 | Stewart; Ernest Glading | Sunscreen formulation with avobenzone and method for stabilizing sunscreen formulation which contains avobenzone |
US6153177A (en) * | 1997-12-15 | 2000-11-28 | Chesebrough-Ponds's Usa, Co., Division Of Conopco, Inc. | Skin lightening composition |
US6171581B1 (en) * | 1998-12-18 | 2001-01-09 | Revlon Consumer Products Corporation | Water and oil emulsion solid antiperspirant/deodorant compositions |
US6171601B1 (en) * | 1996-12-20 | 2001-01-09 | The Procter & Gamble Company | Low residue antiperspirant gel-solid stick compositions |
US6183730B1 (en) * | 1999-05-18 | 2001-02-06 | The Procter & Gamble Company | Antiperspirant and deodorant compositions containing cyclohexasiloxane |
US6197343B1 (en) * | 1996-04-01 | 2001-03-06 | Kao Corporation | Skin color improver |
US6280764B1 (en) * | 1995-06-20 | 2001-08-28 | Lavipharm Laboratories Inc. | Device for topical treatment of acne and its method of manufacture |
US6352688B1 (en) * | 2000-05-17 | 2002-03-05 | The Procter & Gamble Company | High efficacy, low residue antiperspirant stick compositions |
US6365137B1 (en) * | 1999-04-06 | 2002-04-02 | Collaborative Laboratories, Inc. | Skin whitening agents |
US6423325B1 (en) * | 1999-07-30 | 2002-07-23 | Conopco, Inc. | Skin care composition |
US20020106384A1 (en) * | 1999-12-10 | 2002-08-08 | Zhang Kelly Hua | Cosmetic compositions and methods for lightening the skin |
US20020192243A1 (en) * | 1999-12-16 | 2002-12-19 | Tsung-Min Hsu | Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers |
US6680285B2 (en) * | 2000-12-21 | 2004-01-20 | Unilever Home & Personal Care Usa A Division Of Conopco, Inc. | Skin cleansing bar with high levels of liquid emollient |
US20040044078A1 (en) * | 2000-11-29 | 2004-03-04 | Rolf Kawa | Cosmetic and/or pharmaceutical emulsions |
US20040043044A1 (en) * | 2000-06-30 | 2004-03-04 | Granger Stewart Paton | Skin conditioning compositions containing compounds for mimicking the effect on skin of retinoic acid |
US6713051B2 (en) * | 2001-06-18 | 2004-03-30 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Antiperspirant or deodorant compositions |
US20040081672A1 (en) * | 2002-10-25 | 2004-04-29 | Gupta Shyam K. | Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging |
US20040208902A1 (en) * | 2003-04-18 | 2004-10-21 | Gupta Shyam K. | Controlled-release nano-diffusion delivery systems for cosmetic and pharmaceutical compositions |
US20040253275A1 (en) * | 2000-01-10 | 2004-12-16 | Meir Eini | Pharmaceutical and cosmetic carrier or composition for topical application |
US6835373B2 (en) * | 2002-07-12 | 2004-12-28 | The Procter & Gamble Company | Non-irritating antiperspirant compositions containing acidic antiperspirant active |
US6849251B2 (en) * | 2000-04-28 | 2005-02-01 | Henkel Kommanditgesellschaft Auf Aktien | Anhydrous antiperspirant composition containing polysaccharides |
US6875425B2 (en) * | 2002-12-12 | 2005-04-05 | Unilever Home & Personal Care Usa | Skin lightening agents, compositions and methods |
US20050120917A1 (en) * | 2003-12-09 | 2005-06-09 | Reinhold Ruger | Coloured microstructured effect pigments |
US6932984B1 (en) * | 1999-11-17 | 2005-08-23 | Tagra Biotechnologies Ltd. | Method of microencapsulation |
US6936242B2 (en) * | 2002-11-15 | 2005-08-30 | The Gillette Company | Multi-portion antiperspirant composition |
US20050220726A1 (en) * | 2002-03-01 | 2005-10-06 | Gilles Pauly | Use of sugar esters in cosmetic and/or pharmaceutical preparations |
US20060067960A1 (en) * | 2004-09-30 | 2006-03-30 | Russ Julio G | Color cosmetic compositions |
US20060115441A1 (en) * | 2004-11-26 | 2006-06-01 | Conopco Inc, D/B/A Unilever | Underarm cosmetic method and compositions |
US7247294B1 (en) * | 2006-03-30 | 2007-07-24 | Conopco, Inc. | Skin lightening agents, compositions and methods |
US7250158B1 (en) * | 2006-03-30 | 2007-07-31 | Conopco, Inc. | Skin lightening agents, compositions and methods |
US20070253911A1 (en) * | 2002-10-25 | 2007-11-01 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US20080193393A1 (en) * | 2004-09-24 | 2008-08-14 | Lipo Chemicals Inc. | Delivery System for Topically Applied Compounds |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63115809A (en) * | 1986-10-31 | 1988-05-20 | Kanebo Ltd | Skin cosmetic |
US5389677B1 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Method of treating wrinkles using glycalic acid |
IN169917B (en) | 1989-03-21 | 1992-01-11 | Lever Hindustan Ltd | |
JPH05345705A (en) | 1992-02-03 | 1993-12-27 | Nippon Shinyaku Co Ltd | Skin-beautifying cosmetic composition |
JPH05306231A (en) | 1992-04-24 | 1993-11-19 | Pola Chem Ind Inc | Skin external preparation |
JP3480952B2 (en) | 1992-08-17 | 2003-12-22 | 株式会社コーセー | External preparation for skin |
JPH06227939A (en) * | 1993-02-05 | 1994-08-16 | Yuka Sangyo Kk | Cosmetic |
JPH0725742A (en) | 1993-07-15 | 1995-01-27 | Kao Corp | Fair-skinning cosmetic |
JP3025605B2 (en) | 1993-07-21 | 2000-03-27 | 花王株式会社 | Whitening cosmetics |
JPH07238010A (en) * | 1994-02-24 | 1995-09-12 | Kanebo Ltd | Skin cosmetic |
JP3696271B2 (en) | 1994-09-22 | 2005-09-14 | 花王株式会社 | Whitening cosmetics |
JPH0892055A (en) | 1994-09-22 | 1996-04-09 | Kao Corp | Whitening cosmetic |
FR2735688B1 (en) * | 1995-06-26 | 1997-08-14 | Oreal | USE IN COMBINATION OF AN ALPHA-HYDROXYACID AND A TITANIUM OXIDE FOR SKIN WHITENING |
JPH0987135A (en) | 1995-07-13 | 1997-03-31 | Shiseido Co Ltd | Dermal preparation for external use |
JPH0952817A (en) | 1995-08-09 | 1997-02-25 | Kao Corp | Beautifying and whitening cosmetic |
JP3645633B2 (en) | 1995-12-13 | 2005-05-11 | 花王株式会社 | Whitening cosmetics |
JPH10203921A (en) | 1997-01-20 | 1998-08-04 | Shiseido Co Ltd | Skin preparation for external use |
JPH10265322A (en) | 1997-03-19 | 1998-10-06 | Shiseido Co Ltd | Skin preparation for external use |
JPH10265321A (en) | 1997-03-19 | 1998-10-06 | Shiseido Co Ltd | Skin preparation for external use |
JP3592918B2 (en) | 1997-05-14 | 2004-11-24 | 花王株式会社 | Cosmetics |
RO118174B1 (en) * | 1997-08-21 | 2003-03-28 | Aventis Pharma Deutschland Gmbh | Nail polish and use thereof |
JPH11124308A (en) | 1997-10-22 | 1999-05-11 | Kao Corp | Cosmetic |
JPH11246343A (en) | 1998-02-27 | 1999-09-14 | Shiseido Co Ltd | Preparation for external use for skin bleaching |
JP2000143479A (en) | 1998-11-05 | 2000-05-23 | Kao Corp | Skin-bleaching cosmetic |
JP2000302661A (en) | 1999-04-21 | 2000-10-31 | Kao Corp | Cosmetic |
JP2001163755A (en) | 1999-12-07 | 2001-06-19 | Shiseido Co Ltd | Preparation for external use for skin |
JP2001181173A (en) | 1999-12-27 | 2001-07-03 | Kose Corp | Bleaching preparation for external use |
JP2001206833A (en) | 2000-01-25 | 2001-07-31 | Kao Corp | Cosmetic |
GB0006867D0 (en) * | 2000-03-21 | 2000-05-10 | Unilever Plc | Method and composition for skin lightening |
US6881414B2 (en) * | 2000-11-22 | 2005-04-19 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Mild cosmetic composition with stabilized retinoids |
JP2002179516A (en) | 2000-12-13 | 2002-06-26 | Pola Chem Ind Inc | Skin-whitening composition |
JP2002265387A (en) | 2001-03-06 | 2002-09-18 | Kose Corp | Skin care preparation |
JP2002284664A (en) | 2001-03-29 | 2002-10-03 | Shiseido Co Ltd | External skin preparation for whitening |
GB0119583D0 (en) | 2001-08-10 | 2001-10-03 | Unilever Plc | Cosmetic composition and method of treating skin |
JP3934371B2 (en) | 2001-08-15 | 2007-06-20 | 玲子 渡久地 | Beauty soap |
JP2003128521A (en) | 2001-10-16 | 2003-05-08 | Rohto Pharmaceut Co Ltd | External preparation |
JP2003306419A (en) | 2002-04-16 | 2003-10-28 | Nikko Chemical Co Ltd | Cosmetic |
WO2004010960A1 (en) | 2002-07-25 | 2004-02-05 | Amcol International Corporation | Viscous compositions containing hydrophobic liquids |
JP2004075645A (en) | 2002-08-22 | 2004-03-11 | Kanebo Ltd | Cosmetic |
DE10238449A1 (en) | 2002-08-22 | 2004-03-04 | Beiersdorf Ag | Cosmetic and / or dermatological preparation |
JP2004115381A (en) | 2002-09-24 | 2004-04-15 | Shiseido Co Ltd | External preparation for skin |
JP2004238394A (en) | 2003-01-17 | 2004-08-26 | Kose Corp | Rebound inhibitor and skin care preparation for external use containing the same |
JP2004262853A (en) | 2003-03-03 | 2004-09-24 | Kanebo Ltd | Cosmetic |
JP2005002050A (en) | 2003-06-12 | 2005-01-06 | Shiseido Co Ltd | Bleaching agent and skin care preparation for external use formulated therewith |
TW200607529A (en) | 2004-07-28 | 2006-03-01 | Cream Holdings Pty Ltd | Natural sunscreen composition |
JP2006219423A (en) | 2005-02-10 | 2006-08-24 | Kao Corp | Skin cosmetic |
JP5137256B2 (en) * | 2005-03-31 | 2013-02-06 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Enhanced delivery of skin benefit agents |
CN101146509B (en) * | 2005-03-31 | 2012-10-10 | 荷兰联合利华有限公司 | Enhanced delivery of skin benefit agents |
EP1888015A1 (en) | 2005-05-03 | 2008-02-20 | Unilever Plc | Skin lightening composition comprising a conjugated linoleic acid and niacinamide |
JP2009508895A (en) | 2005-09-23 | 2009-03-05 | ディーエスエム アイピー アセッツ ビー.ブイ. | Use of opioid receptor antagonists |
ITBA20060049A1 (en) | 2006-08-02 | 2008-02-03 | Pierre S R L | FOOD SUPPLEMENT BASED ON BIOLOGICAL LYCOPENE AND PROCEDURE FOR OBTAINING BIOLOGICAL LICOPENE. |
JP2008150314A (en) | 2006-12-18 | 2008-07-03 | Shiseido Co Ltd | Bleaching agent |
TWI454261B (en) | 2007-01-09 | 2014-10-01 | Unigen Inc | Chromones as therapeutic agents |
KR100823533B1 (en) | 2007-02-27 | 2008-04-30 | 바이오스펙트럼 주식회사 | COMPOSITIONS FOR IMPROVING SKIN CONDITIONS COMPRISING alpha;-BISABOLOL AS AN ACTIVE INGREDIENT |
US20090317341A1 (en) * | 2008-06-18 | 2009-12-24 | Conopco, Inc., D/B/A Unilever | Compositions for Lightening Skin Color |
US8247405B2 (en) * | 2008-12-10 | 2012-08-21 | Conopco, Inc. | Skin lightening compositions with acetylcholinesterase inhibitors |
-
2008
- 2008-06-18 US US12/141,561 patent/US20090317341A1/en not_active Abandoned
-
2009
- 2009-06-04 KR KR1020167010797A patent/KR101788998B1/en active IP Right Grant
- 2009-06-04 CN CN201711095416.6A patent/CN108158836A/en active Pending
- 2009-06-04 PL PL14163576T patent/PL2752184T3/en unknown
- 2009-06-04 EP EP16177361.9A patent/EP3103434B1/en active Active
- 2009-06-04 MX MX2010014098A patent/MX2010014098A/en active IP Right Grant
- 2009-06-04 CN CN200980122854.4A patent/CN102065829B/en active Active
- 2009-06-04 KR KR1020107028407A patent/KR101617478B1/en active IP Right Grant
- 2009-06-04 AU AU2009259483A patent/AU2009259483B2/en active Active
- 2009-06-04 ES ES14163576.3T patent/ES2611791T3/en active Active
- 2009-06-04 CA CA2728978A patent/CA2728978C/en active Active
- 2009-06-04 PL PL09765749T patent/PL2285342T3/en unknown
- 2009-06-04 CN CN201410170094.7A patent/CN103976889B/en active Active
- 2009-06-04 EP EP14163576.3A patent/EP2752184B1/en active Active
- 2009-06-04 ES ES09765749.8T patent/ES2511916T3/en active Active
- 2009-06-04 WO PCT/EP2009/056886 patent/WO2009153169A1/en active Application Filing
- 2009-06-04 EP EP09765749.8A patent/EP2285342B9/en active Active
- 2009-06-04 EA EA201170042A patent/EA018806B1/en not_active IP Right Cessation
- 2009-06-04 JP JP2011513979A patent/JP5620908B2/en active Active
- 2009-06-04 BR BRPI0914843-4A patent/BRPI0914843B1/en active IP Right Grant
- 2009-06-04 EA EA201300756A patent/EA026945B1/en not_active IP Right Cessation
- 2009-06-10 SA SA109300373A patent/SA109300373B1/en unknown
- 2009-06-12 TW TW098119831A patent/TWI442943B/en active
- 2009-06-17 AR ARP090102190A patent/AR072165A1/en active IP Right Grant
-
2010
- 2010-10-20 US US12/908,248 patent/US9227090B2/en active Active
- 2010-12-07 ZA ZA2010/08792A patent/ZA201008792B/en unknown
- 2010-12-17 CL CL2010001461A patent/CL2010001461A1/en unknown
-
2011
- 2011-08-11 HK HK11108430.8A patent/HK1153954A1/en unknown
-
2015
- 2015-02-10 HK HK15101435.4A patent/HK1200737A1/en unknown
- 2015-11-23 US US14/948,461 patent/US20160074295A1/en not_active Abandoned
-
2019
- 2019-04-10 US US16/380,657 patent/US20190336424A1/en not_active Abandoned
Patent Citations (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4096240A (en) * | 1975-04-10 | 1978-06-20 | Lever Brothers Company | Skin lightening composition and method |
US5262153A (en) * | 1989-09-20 | 1993-11-16 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkujo | Skin-whitening agent |
JPH05201847A (en) * | 1992-01-28 | 1993-08-10 | Sunstar Inc | Skin-beautifying cosmetic |
US5429816A (en) * | 1992-05-12 | 1995-07-04 | Procter & Gamble | Antiperspirant gel stick compositions |
US5399785A (en) * | 1992-08-05 | 1995-03-21 | Nippon Paint Co., Ltd. | Tyrosinase activity inhibitor |
US5591424A (en) * | 1993-06-30 | 1997-01-07 | The Procter & Gamble Company | Antiperspirant gel stick compositions |
US5650144A (en) * | 1993-06-30 | 1997-07-22 | The Procter & Gamble Co. | Antiperspirant gel stick compositions |
US5516511A (en) * | 1994-05-06 | 1996-05-14 | The Procter & Gamble Company | Antiperspirant gel compositions comprising chelators |
US6280764B1 (en) * | 1995-06-20 | 2001-08-28 | Lavipharm Laboratories Inc. | Device for topical treatment of acne and its method of manufacture |
US6197343B1 (en) * | 1996-04-01 | 2001-03-06 | Kao Corporation | Skin color improver |
US5998423A (en) * | 1996-10-08 | 1999-12-07 | Therasys, Inc. | Methods for modulating melanin production |
US6171601B1 (en) * | 1996-12-20 | 2001-01-09 | The Procter & Gamble Company | Low residue antiperspirant gel-solid stick compositions |
US5744130A (en) * | 1996-12-20 | 1998-04-28 | The Procter & Gamble Company | Antiperspirant gel-solid stick compositions substantially free of select polar solvents |
US5776494A (en) * | 1996-12-20 | 1998-07-07 | The Procter & Gamble Company | Pharmaceuticals compositions containing gellants in the form of alkyl amides of di-and tri-carboxylic acids |
US5863546A (en) * | 1997-03-02 | 1999-01-26 | Swinehart; James M | Cosmetic composition |
US6090369A (en) * | 1997-06-04 | 2000-07-18 | Stewart; Ernest Glading | Sunscreen formulation with avobenzone and method for stabilizing sunscreen formulation which contains avobenzone |
US5965113A (en) * | 1997-06-23 | 1999-10-12 | Procter & Gamble Company | Low residue antiperspirant gel-solid stick compositions containing volatile nonpolar hydrocarbon solvents |
US6153177A (en) * | 1997-12-15 | 2000-11-28 | Chesebrough-Ponds's Usa, Co., Division Of Conopco, Inc. | Skin lightening composition |
US5968489A (en) * | 1998-05-01 | 1999-10-19 | The Procter & Gamble Company | Antiperspirant composition containing 1,2-hexanediol |
US6139880A (en) * | 1998-06-10 | 2000-10-31 | Revlon Consumer Products Corporation | Gel cosmetic compositions |
US6033651A (en) * | 1998-06-10 | 2000-03-07 | Revlon Consumer Products Corporation | Gel cosmetic compositions |
US6171581B1 (en) * | 1998-12-18 | 2001-01-09 | Revlon Consumer Products Corporation | Water and oil emulsion solid antiperspirant/deodorant compositions |
US6365137B1 (en) * | 1999-04-06 | 2002-04-02 | Collaborative Laboratories, Inc. | Skin whitening agents |
US6183730B1 (en) * | 1999-05-18 | 2001-02-06 | The Procter & Gamble Company | Antiperspirant and deodorant compositions containing cyclohexasiloxane |
US6423325B1 (en) * | 1999-07-30 | 2002-07-23 | Conopco, Inc. | Skin care composition |
US6932984B1 (en) * | 1999-11-17 | 2005-08-23 | Tagra Biotechnologies Ltd. | Method of microencapsulation |
US20020106384A1 (en) * | 1999-12-10 | 2002-08-08 | Zhang Kelly Hua | Cosmetic compositions and methods for lightening the skin |
US20020192243A1 (en) * | 1999-12-16 | 2002-12-19 | Tsung-Min Hsu | Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers |
US20040253275A1 (en) * | 2000-01-10 | 2004-12-16 | Meir Eini | Pharmaceutical and cosmetic carrier or composition for topical application |
US6849251B2 (en) * | 2000-04-28 | 2005-02-01 | Henkel Kommanditgesellschaft Auf Aktien | Anhydrous antiperspirant composition containing polysaccharides |
US6352688B1 (en) * | 2000-05-17 | 2002-03-05 | The Procter & Gamble Company | High efficacy, low residue antiperspirant stick compositions |
US20040043044A1 (en) * | 2000-06-30 | 2004-03-04 | Granger Stewart Paton | Skin conditioning compositions containing compounds for mimicking the effect on skin of retinoic acid |
US20040044078A1 (en) * | 2000-11-29 | 2004-03-04 | Rolf Kawa | Cosmetic and/or pharmaceutical emulsions |
US6680285B2 (en) * | 2000-12-21 | 2004-01-20 | Unilever Home & Personal Care Usa A Division Of Conopco, Inc. | Skin cleansing bar with high levels of liquid emollient |
US6713051B2 (en) * | 2001-06-18 | 2004-03-30 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Antiperspirant or deodorant compositions |
US20050220726A1 (en) * | 2002-03-01 | 2005-10-06 | Gilles Pauly | Use of sugar esters in cosmetic and/or pharmaceutical preparations |
US6835373B2 (en) * | 2002-07-12 | 2004-12-28 | The Procter & Gamble Company | Non-irritating antiperspirant compositions containing acidic antiperspirant active |
US20040081672A1 (en) * | 2002-10-25 | 2004-04-29 | Gupta Shyam K. | Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging |
US20070253911A1 (en) * | 2002-10-25 | 2007-11-01 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US6936242B2 (en) * | 2002-11-15 | 2005-08-30 | The Gillette Company | Multi-portion antiperspirant composition |
US6875425B2 (en) * | 2002-12-12 | 2005-04-05 | Unilever Home & Personal Care Usa | Skin lightening agents, compositions and methods |
US20040208902A1 (en) * | 2003-04-18 | 2004-10-21 | Gupta Shyam K. | Controlled-release nano-diffusion delivery systems for cosmetic and pharmaceutical compositions |
US20050120917A1 (en) * | 2003-12-09 | 2005-06-09 | Reinhold Ruger | Coloured microstructured effect pigments |
US20080193393A1 (en) * | 2004-09-24 | 2008-08-14 | Lipo Chemicals Inc. | Delivery System for Topically Applied Compounds |
US20060067960A1 (en) * | 2004-09-30 | 2006-03-30 | Russ Julio G | Color cosmetic compositions |
US20060115441A1 (en) * | 2004-11-26 | 2006-06-01 | Conopco Inc, D/B/A Unilever | Underarm cosmetic method and compositions |
US7247294B1 (en) * | 2006-03-30 | 2007-07-24 | Conopco, Inc. | Skin lightening agents, compositions and methods |
US7250158B1 (en) * | 2006-03-30 | 2007-07-31 | Conopco, Inc. | Skin lightening agents, compositions and methods |
Non-Patent Citations (1)
Title |
---|
Wineski et al. 1989. Phenoxyethanol as a nontoxic preservative in the dissection laboratory. Acta Anat (Basel); 136(2): (abstract). * |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9956257B2 (en) | 2005-10-27 | 2018-05-01 | KGK Science, Inc. | Canola extracts containing high levels of phenolic acids |
US9539190B2 (en) | 2010-05-07 | 2017-01-10 | Conopco, Inc. | Skin conditioning compositions containing 12-hydroxystearic acid |
WO2012061991A1 (en) | 2010-11-11 | 2012-05-18 | Unilever Plc | Leave-on nonsolid skin conditioning compositions containing 12-hydroxystearic acid |
WO2012062554A2 (en) | 2010-11-11 | 2012-05-18 | Unilever Plc | Leave-on non-solid skin conditioning compositions containing 12-[(12-hydroxyoctadecanoyl)oxy] octadecanoic acid |
CN103189109A (en) * | 2010-11-11 | 2013-07-03 | 荷兰联合利华有限公司 | Leave-on non-solid skin conditioning compositions containing 12-[(12-hydroxyoctadecanoyl)oxy] octadecanoic acid |
WO2012080272A2 (en) | 2010-12-15 | 2012-06-21 | Unilever Plc | Leave-on non-solid skin conditioning compositions containing 12-hydroxystearic acid and ethoxylated hydrogenated castor oil |
US8613939B2 (en) | 2010-12-15 | 2013-12-24 | Conopco, Inc. | Leave-on nonsolid skin conditioning compositions containing 12-hydroxystearic acid and ethoxylated hydrogenated castor oil |
EA025588B1 (en) * | 2011-02-17 | 2017-01-30 | Унилевер Н.В. | Leave-on non-solid skin conditioning composition which has a continuous oil phase and contains 12-hydroxystearic acid |
WO2012110276A1 (en) | 2011-02-17 | 2012-08-23 | Unilever Plc | Leave -on non- solid skin conditioning composition which has a continuous phase and contains 12 - hydroxystearic acid |
WO2013068345A2 (en) | 2011-11-11 | 2013-05-16 | Unilever Plc | Organogel structured with 12-hsa and a selected copolymer |
US9744109B2 (en) | 2012-12-20 | 2017-08-29 | Conopco. Inc. | Eutectic mixtures in personal care compositions |
EA028959B1 (en) * | 2012-12-20 | 2018-01-31 | Юнилевер Н.В. | Eutectic mixtures in personal care compositions |
WO2014095257A1 (en) * | 2012-12-20 | 2014-06-26 | Unilever N.V. | Eutectic mixtures in personal care compositions |
US10172772B2 (en) * | 2013-01-31 | 2019-01-08 | KGK Science, Inc. | Methods of skin whitening by use of canola extracts |
US11896696B2 (en) | 2013-01-31 | 2024-02-13 | 1242753 Ontario Inc. | Methods of skin whitening by use of canola extracts |
US9597271B2 (en) | 2013-10-24 | 2017-03-21 | The Procter & Gamble Company | Cosmetic compositions and methods |
US10660836B2 (en) | 2015-12-22 | 2020-05-26 | Conopco, Inc. | Hydroxy functionalized solvent based skin benefit composition |
CN116056684A (en) * | 2020-07-30 | 2023-05-02 | 联合利华知识产权控股有限公司 | Personal care compositions comprising atractylenolide-I or a source of atractylenolide-I |
US20220202670A1 (en) * | 2020-12-30 | 2022-06-30 | Galaxy Surfactants Ltd. | Personal and home care compositions comprising fatty acids from tung seed oil as antimicrobial preservative |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9227090B2 (en) | Method for lightening skin | |
US8247405B2 (en) | Skin lightening compositions with acetylcholinesterase inhibitors | |
US20100034763A1 (en) | Skin Lightening Composition Comprising CO2 Extracts | |
AU2013202356B2 (en) | Compositions for lightening skin color | |
US20100158829A1 (en) | Method and Composition for Color Modulation | |
US20070183995A1 (en) | Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same | |
US11419803B2 (en) | Skin darkening composition | |
US11433012B2 (en) | Peptides for increasing melanin in melanocytes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CONOPCO, INC., D/B/A UNILEVER, NEW JERSEY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MADISON, STEPHEN ALAN;REEL/FRAME:021421/0022 Effective date: 20080702 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |